Targeting COX-2 abrogates mammary tumorigenesis: Breaking cancer-associated suppression of immunosurveillance.

Markosyan, Nune; Chen, Edward P; Smyth, Emer M

Markosyan, Nune; Chen, Edward P; Smyth, Emer M.

Afiliação

Markosyan N; Institute for Translational Medicine and Therapeutics and Department of Pharmacology; University of Pennsylvania; Philadelphia, PA USA.
Chen EP; Institute for Translational Medicine and Therapeutics and Department of Pharmacology; University of Pennsylvania; Philadelphia, PA USA.
Smyth EM; Institute for Translational Medicine and Therapeutics and Department of Pharmacology; University of Pennsylvania; Philadelphia, PA USA.

Oncoimmunology ; 3: e29287, 2014.

Article em En | MEDLINE | ID: mdl-25114833

Palavras-chave

breast cancer; cyclooxygenase-2; microenvironment; targeted therapy; tumor immune function

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google